Drug-drug Interactions Between DWC202211 & DWC202212 in Healthy Subjects

See also
Status	Clinical Trial	Phase
Completed	`NCT05692570` - A Study of PBI-200 With Ritonavir or Cobicistat in Healthy Volunteers	Phase 1
Completed	`NCT04328766` - Pharmacokinetic Interaction Between DWP14012 and DWC202005 in Healthy Volunteers	Phase 1
Completed	`NCT03990129` - Pharmacokinetic Interactions of Metamizole (Dipyrone) in Healthy Subjects	Phase 1
Completed	`NCT03985969` - Study to Investigate the Potential Drug-Drug Interaction Between Elafibranor and Indomethacin	Phase 1
Completed	`NCT03302845` - A Phase 1 Study to Evaluate the Effects of Omeprazole and Famotidine on the Absorption of Telotristat Ethyl in Healthy Subjects	Phase 1
Completed	`NCT02887443` - A Study to Assess the Potential for Pre-systemic Inhibition of CYP3A by Idebenone Using Midazolam as a Substrate	Phase 1
Completed	`NCT01361217` - The Effects of Multiple Dose Fluoxetine and Metabolites on CYP1A2, CYP2C19, CYP2D6 and CYP3A4 Activity	N/A
Completed	`NCT06066060` - A DDI Study of JMKX000623 and Metformin Hydrochloride	Phase 1
Completed	`NCT03723395` - A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib	Phase 1
Recruiting	`NCT05789173` - Interaction of CYP2B6 Genotype and Efavirenz With Methadone and Tizanidine PK	Early Phase 1
Completed	`NCT04598542` - Drug-Drug Interaction Study of Lorecivivint and Triamcinolone Acetonide in Healthy Volunteers	Phase 1
Recruiting	`NCT05044962` - Kuwa Free! - Live Free!	N/A
Completed	`NCT04487145` - Dihydroartemisinin-Piperaquine in the Context of Antiretroviral Therapy	Phase 4
Completed	`NCT05108051` - Study to Investigate the Potential Drug-Drug Interaction Between ZSP1273 and Oseltamivir	Phase 1
Active, not recruiting	`NCT04669678` - Evaluation of Pharmacokinetic Drug-drug Interactions Between Hormonal Contraceptives and Doravirine-containing ART Among Women Living With HIV in South Africa	Phase 4
Completed	`NCT01991327` - Assessment of Drug-Drug Interactions of Androxal With Cytochrome P450 Isoenyzmes in Healthy Males	Phase 1
Completed	`NCT04218513` - Drug-drug Interaction Study Between Edaravone and 2-Aminoethanesulfonic Acid in Compound Edaravone Injection	Phase 1
Completed	`NCT05492318` - Perpetrator DDI Potential of Givinostat as Inhibitor and Inducer of CYP3A and P-gp Activity	Phase 1
Completed	`NCT01309854` - Effects of Administration of Fostamatinib on Blood Concentrations of Pioglitazone in Healthy Subjects	Phase 1
Recruiting	`NCT05339672` - Determining the Clinical Relevance of the Interaction Between Enzalutamide and the Opioid Morphine and the DOAC Edoxaban

NCT number	NCT05699070
Study type	Interventional
Source	Daewoong Pharmaceutical Co. LTD.
Contact
Status	Enrolling by invitation
Phase	Phase 1
Start date	February 15, 2023
Completion date	June 1, 2023

Drug-drug Interactions Between DWC202211 and DWC202212 in Healthy Subjects — DWJ1610

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms